Medical News

RSS

Seattle genetics new blood cancer drug Adcetris comes with a hefty price tag

Seattle Genetics Inc's new blood cancer drug Adcetris is will come with a price tag of $100,000 for a course of treatment. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first drug specifically indicated for anaplastic large cell lymphoma (ALCL) and the first one approved for Hodgkin's lymphoma since 1977.

23 Aug 2011

Dogs ‘sniff’ out early lung cancer accurately

According to a new study in the European Respiratory Journal dogs are better at sniffing out the early markers of lung cancer than the latest medical technologies at our disposal.

23 Aug 2011

Fewer children falling from windows thanks to safety measures

According to a new study in the journal Pediatrics, pediatric injury rates in the United States where children fall off from windows has steadily decreased during a 19-year period, but these declines could be more substantial if comprehensive prevention programs similar to those launched in New York City and Boston were adopted nationwide.

23 Aug 2011

Hospital acquired Clostridium difficile bug defense system identified

American researchers have discovered the process by which the cells in the gut fight off toxins produced by a hospital bug - Clostridium difficile. Writing in Nature Medicine, they showed how a chemical - GSNO - deactivated a toxin from Clostridium difficile which causes inflammation and diarrhea. They hope to use their findings to develop a treatment for C. difficile.

23 Aug 2011

MedPro Safety Products second quarter net loss decreases to $2.9 million

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.

23 Aug 2011

Seeing provides the big picture, but exploration burns it into memory

Seeing and exploring both are necessary for stability in a person's episodic memory when taking in a new experience, say University of Oregon researchers.

23 Aug 2011

Hutchinson Center to participate in NCI-funded proteome research consortium

The National Cancer Institute today announced that a team co-led by Fred Hutchinson Cancer Research Center and The Broad Institute in Cambridge, Mass., has been selected to participate in a National Cancer Institute-funded research consortium dedicated to understanding the molecular basis of cancer.

23 Aug 2011

BioLineRx second quarter net loss decreases to NIS 16.4 million

BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the second quarter ending June 30, 2011.

23 Aug 2011

MicroRNA biomarkers provide guidance to develop specific gene therapies for glioblastoma

Patients suffering from an aggressive brain cancer will benefit from the results of a University of Illinois study that could advance the development of targeted gene therapies and improve prognosis.

23 Aug 2011

Roche Canada grants Vasculitis and Scleroderma Fellowship

Roche Canada announced today its support of a Vasculitis and Scleroderma Fellowship through the Division of Rheumatology at the University of British Columbia (UBC). Dr. Ada Man, a recent graduate of the UBC rheumatology residency program, is the recipient of the one-year Fellowship.

23 Aug 2011

Researchers show that Sirt3 enzyme decreases in skeletal muscle of diabetes patients

Researchers at the Joslin Diabetes Center have shown that an enzyme found in the mitochondria of cells is decreased in the skeletal muscle of those with diabetes, a finding that could lead to the development of drugs to boost the activity of this enzyme in an effort to fight the disease.

23 Aug 2011

Research reveals significant increase in infections associated with cardiac electrophysiological devices

New research from the Jefferson Heart Institute shows that patients in the United States who receive cardiac electrophysiological devices (CIEDs), including permanent pacemakers and implantable cardioverter-defibrillators (ICDs) are now at greater risk of contracting an infection over the life span of the device.

23 Aug 2011

FDA clears IQuum's Liat influenza A/B assay, analyzer

IQuum, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Liat Influenza A/B Assay and the Liat Analyzer.

23 Aug 2011

Medtronic first quarter global revenue increases 7% to $4.049 billion

Medtronic, Inc. today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011.

From Medtronic 23 Aug 2011

Best Practices publishes updated Medical Science Liaison-focused report

With the support of Key Opinion Leaders clearly linked to success in the marketplace, competition for the time and attention of KOLs is intensifying. But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships.

23 Aug 2011

AHF criticizes HHS for delays and mistakes in distributing HIV/AIDS funds

Today, AIDS Healthcare Foundation (AHF) criticized the U.S. Department of Health & Human Services (HHS) agency for delays and mistakes in distributing funds through the Ryan White CARE Act, the largest federal program dedicated to providing care and treatment for people living with HIV. Despite an HHS statement to the contrary, the Foundation says that delays in funding are hurting programs that serve people living with HIV/AIDS across the nation.

23 Aug 2011

Kerr, Family Health Network partner to reduce medication non-adherence

Family Health Network is pleased to announce its participation in a program in partnership with Kerr Health, a subsidiary of the renowned regional pharmacy chain, Kerr Drug. Kerr Health will deploy Family Health Network's Connected for Life(SM) platform to an initial group of patients who require frequent interaction with a pharmacist to assist them with medication therapy management.

23 Aug 2011